The science is catching up: A major RCT of semaglutide in type 1 by Viral Shah et Al just landed in NEJM
Addressing this gap requires collaboration between the government, doctors, and patient advocacy groups to reduce the growing burden of obesity. He underlined the stakes, suggesting how obesity is linked with 229 different conditions, including joint pain, memory decline, anxiety, depression, gout, respiratory disorders, and even cancer
Delayed gastric emptying poses particular concerns in the post-operative setting
Bifidobacterium longum
Liraglutide can increase macrophage fibroblast growth factor 21 (FGF21) secretion and activate FGFR3 in the WAT and macrophages (Zhang et al., 2021)
Does Cagrilintide cause pancreatitis